BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 24304881)

  • 1. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain.
    Hashimura Y; Nozu K; Kaito H; Nakanishi K; Fu XJ; Ohtsubo H; Hashimoto F; Oka M; Ninchoji T; Ishimori S; Morisada N; Matsunoshita N; Kamiyoshi N; Yoshikawa N; Iijima K
    Kidney Int; 2014 May; 85(5):1208-13. PubMed ID: 24304881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
    Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
    Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked Alport Syndrome with Type IV Collagen α5 Chain Staining Revealing Normal Expression in the Glomerular Basement Membrane and Negative on Bowman's Capsule and Distal Tubular Basement Membrane: A Case Report.
    Okamoto T; Shima H; Doi T; Nozu K; Inoue T; Tashiro M; Wariishi S; Bando H; Azuma H; Iwasaka N; Ohara T; Okada K; Minakuchi J
    Tohoku J Exp Med; 2023 Sep; 261(1):69-73. PubMed ID: 37495524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.
    Massella L; Gangemi C; Giannakakis K; Crisafi A; Faraggiana T; Fallerini C; Renieri A; Muda AO; Emma F
    Clin J Am Soc Nephrol; 2013 May; 8(5):749-55. PubMed ID: 23371956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
    Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
    Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome.
    Nakanishi K; Iijima K; Kuroda N; Inoue Y; Sado Y; Nakamura H; Yoshikawa N
    J Am Soc Nephrol; 1998 Aug; 9(8):1433-40. PubMed ID: 9697665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and genetic features of X-linked Alport syndrome in men positive for the collagen Ⅳ α5 chain in epidermal basement membrane].
    Zhang Y; Ding J; Wang F; Zhang H; Xiao H; Yao Y; Zhong X; Guan N; Liu X; Yu L; Liu J; Yang J
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):61-4. PubMed ID: 26791927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteins structure changes of COL4A5 gene point mutations and structure-phenotype relations in Alport syndrome].
    Wang YF; Ding J; Wang F; Bu DF
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):589-94. PubMed ID: 15347445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease.
    Massella L; Onetti Muda A; Faraggiana T; Bette C; Renieri A; Rizzoni G
    Kidney Int; 2003 Nov; 64(5):1787-91. PubMed ID: 14531812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked Alport syndrome caused by splicing mutations in COL4A5.
    Nozu K; Vorechovsky I; Kaito H; Fu XJ; Nakanishi K; Hashimura Y; Hashimoto F; Kamei K; Ito S; Kaku Y; Imasawa T; Ushijima K; Shimizu J; Makita Y; Konomoto T; Yoshikawa N; Iijima K
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1958-64. PubMed ID: 25183659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.
    Nabais Sá MJ; Sampaio S; Oliveira A; Alves S; Moura CP; Silva SE; Castro R; Araújo JA; Rodrigues M; Neves F; Seabra J; Soares C; Gaspar MA; Tavares I; Freitas L; Sousa TC; Henriques AC; Costa FT; Morgado E; Sousa FT; Sousa JP; da Costa AG; Filipe R; Garrido J; Montalban J; Ponce P; Alves R; Faria B; Carvalho MF; Pestana M; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):462-7. PubMed ID: 25307721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female X-linked Alport syndrome with somatic mosaicism.
    Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
    Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5.
    Demosthenous P; Voskarides K; Stylianou K; Hadjigavriel M; Arsali M; Patsias C; Georgaki E; Zirogiannis P; Stavrou C; Daphnis E; Pierides A; Deltas C;
    Clin Genet; 2012 Mar; 81(3):240-8. PubMed ID: 21332469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction].
    Wang F; Zhang YQ; Ding J; Yu LX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):760-767. PubMed ID: 29045953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant phenotypic expression of Alport syndrome in monozygotic twins.
    Matsukura H; Higuchi A; Ieki A; Miyawaki T
    Clin Nephrol; 2004 Oct; 62(4):313-8. PubMed ID: 15524063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.